BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12563545)

  • 1. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
    Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
    Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
    Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serotonin transporter promoter polymorphisms on serotonin function.
    Smith GS; Lotrich FE; Malhotra AK; Lee AT; Ma Y; Kramer E; Gregersen PK; Eidelberg D; Pollock BG
    Neuropsychopharmacology; 2004 Dec; 29(12):2226-34. PubMed ID: 15354180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
    Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
    Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
    Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
    Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
    Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
    Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
    Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
    Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter promoter polymorphism in African Americans : allele frequencies and implications for treatment.
    Lotrich FE; Pollock BG; Ferrell RE
    Am J Pharmacogenomics; 2003; 3(2):145-7. PubMed ID: 12749731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine.
    Reist C; Mazzanti C; Vu R; Tran D; Goldman D
    Am J Med Genet; 2001 May; 105(4):363-8. PubMed ID: 11378851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
    Shioe K; Ichimiya T; Suhara T; Takano A; Sudo Y; Yasuno F; Hirano M; Shinohara M; Kagami M; Okubo Y; Nankai M; Kanba S
    Synapse; 2003 Jun; 48(4):184-8. PubMed ID: 12687637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
    Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
    Weizman A; Weizman R
    Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.